This person is not registered. Is this you?


Profile Details
Y Fang
Affiliations:

Johns Hopkins University

Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, HKSAR, China

Fudan University
Department of General Surgery

National Sun Yat-Sen University
Department of Radiology

Center for Human Genome Research, Huazhong University of Science and Technology

Southern Medical University
Department of Gastroenterology

University of Chicago

Johns Hopkins Medicine
Research Institute of Digestive Surgery

Shanghai Jiao Tong University School of Pharmacy

Sun Yat-sen University Cancer Center,
Department of Colorectal Surgery

Shanghai Jiaotong University School of Medicine China

Shanghai Normal University
Department of Mathematics

Physikdepartment der Technischen Universität München
Department of Colorectal Surger

Unknown


 
Baltimore, MD
Phone:
Fax:
My Blogs:
My Twitter Hashtags:
@EyeOfJackieChan
 
Age:
Bio:
[1]Department of Radiology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai 519000, P. R. China.
 
Specialty:
Cancer Biology, Cancer Immunotherapy
 
Presented at Events Covering:
, Antibodies, Bioenergetics, Biology, Biotechnology, Cancer Biology, Cell Biology, Cytokine, Drug Design, Genomics, Microscopy, Molecular Biology, Proteomics, Stem Cells
 
Areas of Interest:
 
Hobbies:
 
General Comments:
BSN Rank: 3024 / 3065 (What's this?)
Accomplish Score: 43
Popularity Score: Unavailable
# in My Circle: 0
# in My Org(s): 30704
We'll Post Your CV for Free!
 
 
Speaking/Presenting-Abstract/Poster at Mtg: 1 (13 / 0)
 
Honors and Awards: 0 (0 / 0)
 
Clinical Trial Activity: 0 (0 / 0)
 
Grant Support: 0 (0 / 0)
 
Patents Pending: 0 (0 / 0)
 
Journal - Editor/Reviewer: 0 (0 / 0)
 
Peer Reviewed Papers, Books, Chapters: 5 (30 / 0)
  • Aging is a major risk factor for age-related diseases such as certain cancers. ()
  • BACKGROUND: The prognosis of pancreatic carcinoma (PC) remains poor and the American Joint Committee on Cancer (AJCC) 8th staging system for survival prediction in PC patients after curative resection is still limited. ()
  • INTRODUCTION: Approximately 5% of primary breast cancer patients present de novo stage IV breast cancer, for whom systematic therapy is the mainstream treatment. ()
 
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
 
Membership in Professional Societies: 0 (0 / 0)
 
White Papers: 0 (0 / 0)
 
Registered on BiotechScienceNews: 0

3D Tissue Models
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.